Kolexia
Degano Bruno Pneumologie
Degano Bruno
Pneumologie
Hôpital Nord Grenoble
La Tronche, France
249 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Broncho-pneumopathie chronique obstructive Hypertension artérielle Hypertension pulmonaire Maladies pulmonaires Hypertension artérielle pulmonaire Bronchopneumopathies obstructives Embolie pulmonaire Fibrose Embolie

Collaborateurs

Voir plus
Soumagne Thibaud
Soumagne Thibaud
Hôpital Européen Georges Pompidou, Paris, France
Dalphin Jean-Charles
Dalphin Jean-Charles
Hôpital Jean-Minjoz, Besançon, France
Laplante Jean-Jacques
Laplante Jean-Jacques
Msa Franche Comte, Besançon, France
Aguilaniu Bernard
Aguilaniu Bernard
Hôpital Nord Grenoble, La Tronche, France

Industries

Voir plus
Menarini
27 collaboration(s)
Dernière en 2023
GSK
24 collaboration(s)
Dernière en 2023
AstraZeneca
18 collaboration(s)
Dernière en 2023
Chiesi
16 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Upfront triple therapy with parenteral prostanoid as a bridge to balloon pulmonary angioplasty in severe chronic thromboembolic pulmonary hypertension.
ERJ open research   04 mars 2024
REVERT: REVErsing Airway Remodelling With Tezepelumab : a Protocol for a Double-blind Randomized Controlled Trial for Patients With Asthma
Essai Clinique (CHU Montpellier)   27 février 2024
Lung cancer, comorbidities, and medication: the infernal trio.
Frontiers in pharmacology   21 février 2024
Fonction respiratoire et FeNO chez l’asthmatique sévère de type 2
Edimark   20 novembre 2023
Hémoptysies : comment faire mieux ?
Edimark   10 septembre 2023
AIRFLOW-3: A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment With the Nuvaira™ Lung Denervation System in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Essai Clinique (Nuvaira, Inc.)   07 septembre 2023
Bronchoscopic COPD treatments.
Revue des maladies respiratoires   06 septembre 2023
Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH): A Multi-centre, Multinational, Open-label, Single-dose Acute Hemodynamic Study Followed by Multi-centre, Multinational, Randomized, Double-blind, Parallel-group, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy (Proof-of-concept) of ACT-293987 (NS-304) in the Treatment of Pulmonary Arterial Hypertension in Subjects Aged 18 Years and Over
Essai Clinique (Actelion)   11 août 2023
Insight into the relationship between forced vital capacity and transfer of the lungs for carbon monoxide in patients with idiopathic pulmonary fibrosis.
Respiratory medicine and research   14 juillet 2023
Development and external validation of a prediction model for the transition from mild to moderate or severe form of COVID-19.
European radiology   05 juillet 2023